-
1
-
-
33645429186
-
Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes
-
The PURSUIT Trial Investigators
-
The PURSUIT Trial Investigators. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. N Engl J Med 1998;97:2386-2395
-
(1998)
N Engl J Med
, vol.97
, pp. 2386-2395
-
-
-
2
-
-
0034676781
-
Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): A randomized, placebo-controlled trial
-
The ESPRIT Investigators. (Erratum in Lancet 2001;357:1370.)
-
The ESPRIT Investigators. Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomized, placebo-controlled trial. Lancet 2000;356: 2037-2044 (Erratum in Lancet 2001;357:1370.)
-
(2000)
Lancet
, vol.356
, pp. 2037-2044
-
-
-
3
-
-
67650826001
-
-
Available from Accessed June 5, 2008
-
U.S. Food and Drug Administration, Center for Drug Evaluation and Research. Drug information page. Integrilin (eptifibatide) injection. Available from http://www.fda.gov/ Cder/foi/nda/98/20718-Integrilin.htm. Accessed June 5, 2008.
-
Drug Information Page. Integrilin (Eptifibatide) Injection
-
-
-
4
-
-
0035880615
-
Association of eptifibatide and acute profound thrombocytopenia
-
DOI 10.1016/S0002-9149(01)01695-2, PII S0002914901016952
-
Hongo RH, Nrent BN. Association of eptifibatide and acute profound thrombocytopenia. Am J Cardiol 2001;88:428-431 (Pubitemid 32823310)
-
(2001)
American Journal of Cardiology
, vol.88
, Issue.4
, pp. 428-431
-
-
Hongo, R.H.1
Brent, B.N.2
-
5
-
-
0036208991
-
Reversible thrombocytopenia associated with eptifibatide
-
Yoder M, Edwards RF. Reversible thrombocytopenia associated with eptifibatide. Ann Pharmacother 2002;36:628-630
-
(2002)
Ann Pharmacother
, vol.36
, pp. 628-630
-
-
Yoder, M.1
Edwards, R.F.2
-
6
-
-
0037369974
-
Acute profound thrombocytopenia associated with eptifibatide therapy
-
DOI 10.1592/phco.23.3.374.32107
-
Nagge J, Jackevicus C, Dzavik V, Ross JR, Seidelin P. Acute profound thrombocytopenia associated with eptifibatide therapy. Pharmacotherapy 2003;23:374-379 (Pubitemid 36259342)
-
(2003)
Pharmacotherapy
, vol.23
, Issue.3
, pp. 374-379
-
-
Nagge, J.1
Jackevicius, C.2
Dzavik, V.3
Ross, J.R.4
Seidelin, P.5
-
7
-
-
0141673293
-
Eptifibatide-induced thrombocytopenia and coronary bypass operation
-
Tanaka KA, Vega JD, Kelly B, Hanson SR, Levy JH. Eptifibatide-induced thrombocytopenia and coronary bypass operation. J Thromb Haemost 2003;1:392-394
-
(2003)
J Thromb Haemost
, vol.1
, pp. 392-394
-
-
Tanaka, K.A.1
Vega, J.D.2
Kelly, B.3
Hanson, S.R.4
Levy, J.H.5
-
8
-
-
1542544816
-
Eptifibatide-induced thrombocytopenia and circulating procoagulant platelet-derived microparticles in a patient with acute coronary syndrome
-
Morel O, Jesel L, Chauvin M, Freyssinet JM, Toti F. Eptifibatide-induced thrombocytopenia and circulating procoagulant platelet-derived microparticles in a patient with acute coronary syndrome. J Thromb Haemost 2003;1:2685-2687
-
(2003)
J Thromb Haemost
, vol.1
, pp. 2685-2687
-
-
Morel, O.1
Jesel, L.2
Chauvin, M.3
Freyssinet, J.M.4
Toti, F.5
-
9
-
-
0037221733
-
Eptifibatide-induced acute profound thrombocytopenia presenting as refractory hypotension
-
DOI 10.1002/ccd.10392
-
Rezkalla SH, Hayes JJ, Curtis BR, Aster RH. Eptifibatideinduced acute profound thrombocytopenia presenting as refractory hypotension. Cathet Cardiovasc Intervent 2003;58:76-79 (Pubitemid 36055306)
-
(2003)
Catheterization and Cardiovascular Interventions
, vol.58
, Issue.1
, pp. 76-79
-
-
Rezkalla, S.H.1
Hayes, J.J.2
Curtis, B.R.3
Aster, R.H.4
-
11
-
-
12844266030
-
Eptifibatideassociated acute, profound thrombocytopenia
-
Coons JC, Barcelona RA, Freedy T, Hagerty MF. Eptifibatideassociated acute, profound thrombocytopenia. Ann Pharmacother 2005;39:368-372
-
(2005)
Ann Pharmacother
, vol.39
, pp. 368-372
-
-
Coons, J.C.1
Barcelona, R.A.2
Freedy, T.3
Hagerty, M.F.4
-
12
-
-
33645293461
-
Recurrent acute profound thrombocytopenia related to readministration of eptifibatide
-
Cheema AA, Teklinski AH, Maria V, Chilukuri K, Frank JJ, Gosselin MO. Recurrent acute profound thrombocytopenia related to readministration of eptifibatide. J Intervent Cardiol 2006;19:99-103.
-
(2006)
J Intervent Cardiol
, vol.19
, pp. 99-103
-
-
Cheema, A.A.1
Teklinski, A.H.2
Maria, V.3
Chilukuri, K.4
Frank, J.J.5
Gosselin, M.O.6
-
13
-
-
33749169202
-
Eptifibatide-induced thrombocytopenia and thrombosis
-
Epelman S, Nair D, Downey R, Militello M, Askari AT. Eptifibatide-induced thrombocytopenia and thrombosis. J Thromb Thrombolysis 2006;22:151-154
-
(2006)
J Thromb Thrombolysis
, vol.22
, pp. 151-154
-
-
Epelman, S.1
Nair, D.2
Downey, R.3
Militello, M.4
Askari, A.T.5
-
14
-
-
0034849557
-
Severe thrombocytopenia possibly related to readministration of eptifibatide
-
DOI 10.1002/ccd.1239
-
Paradiso-Hardy FL, Madan M, Radhakrishnan S, Hurden S, Cohen EA. Severe thrombocytopenia possibly related to readministration of eptifibatide. Cathet Cardiovasc Intervent 2001;54:63-67 (Pubitemid 32851992)
-
(2001)
Catheterization and Cardiovascular Interventions
, vol.54
, Issue.1
, pp. 63-67
-
-
Hansen, A.1
Hehrlein, C.2
Hardt, S.3
Bekeredjian, R.4
Brachmann, J.5
Kubler, W.6
Bode, C.7
Kuecherer, H.F.8
-
16
-
-
33845243141
-
Delayed profound thrombocytopenia associated with eptifibatide [1]
-
DOI 10.1002/ajh.20609
-
Onitilo AA. Delayed profound thrombocytopenia associated with eptifibatide. Am J Hematol 2006;81:984-988 (Pubitemid 44864461)
-
(2006)
American Journal of Hematology
, vol.81
, Issue.12
, pp. 984
-
-
Onitilo, A.A.1
-
17
-
-
0031055038
-
Acute profound thrombocytopenia after c7E3 Fab (Abciximab) therapy
-
Berkowitz SD, Harrington RA, Rund MM, Tcheng JE. Acute profound thrombocytopenia after c7E3 Fab (abciximab) therapy. Circulation 1997;95:809-813 (Pubitemid 27091518)
-
(1997)
Circulation
, vol.95
, Issue.4
, pp. 809-813
-
-
Berkowitz, S.D.1
Harrington, R.A.2
Rund, M.M.3
Tcheng, J.E.4
-
18
-
-
0019799332
-
A method of estimating the probability of adverse drug reactions
-
Naranjo CA, Busto U, Sellers EM, et al. A method of estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-245
-
(1981)
Clin Pharmacol Ther
, vol.30
, pp. 239-245
-
-
Naranjo, C.A.1
Busto, U.2
Sellers, E.M.3
-
19
-
-
0029682565
-
Posttransfusion purpura: Two unusual cases and a literature review
-
DOI 10.1002/(SICI)1096-8652(199607)52:3<205::AID-AJH13>3.0.CO;2-E
-
McCrae KR, Herman JH. Posttransfusion purpura: two unusual cases and a literature review. Am J Hematol 1996;52:205-211 (Pubitemid 26254858)
-
(1996)
American Journal of Hematology
, vol.52
, Issue.3
, pp. 205-211
-
-
McCrae, K.R.1
Herman, J.H.2
-
20
-
-
45949103154
-
Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition)
-
DOI 10.1378/chest.08-0677
-
Warkentin TE, Greinacher A, Koster A, Lincoff AM. Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians evidence-based clinical practice guidelines, 8th ed. Chest 2008;133(6 suppl):S340-80. (Pubitemid 351892970)
-
(2008)
Chest
, vol.133
, Issue.6 SUPPL. 6
-
-
Warkentin, T.E.1
Greinacher, A.2
Koster, A.3
Lincoff, A.M.4
-
21
-
-
34047241060
-
Heparin-induced thrombocytopenia: Treatment options and special considerations
-
DOI 10.1592/phco.27.4.564
-
Dager WE, Dougherty JA, Nguyen PH, Militello MA, Smythe MA. Heparin-induced thrombocytopenia: treatment options and special considerations. Pharmacotherapy 2007;27:564-587 (Pubitemid 46536238)
-
(2007)
Pharmacotherapy
, vol.27
, Issue.4 I
, pp. 564-587
-
-
Dager, W.E.1
Dougherty, J.A.2
Nguyen, P.H.3
Militello, M.A.4
Smythe, M.A.5
-
22
-
-
0035797925
-
Delayed-onset heparin-induced thrombocytopenia and thrombosis
-
Warkentin TE, Kelton JG. Delayed-onset heparin-induced thrombocytopenia and thrombosis. Ann Intern Med 2001; 135:502-506
-
(2001)
Ann Intern Med
, vol.135
, pp. 502-506
-
-
Warkentin, T.E.1
Kelton, J.G.2
-
23
-
-
4644242157
-
Heparin-induced thrombocytopenia: Recognition, treatment, and prevention - The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
-
DOI 10.1378/chest.126.3-suppl.311S
-
Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004:126(3 suppl):S311-37. (Erratum in Chest 2005; 127:416.) (Pubitemid 39297959)
-
(2004)
Chest
, vol.126
, Issue.3 SUPPL.
-
-
Warkentin, T.E.1
Greinacher, A.2
-
24
-
-
0141456652
-
Vancomycin-induced thrombocytopenia: A case proven with rechallenge
-
DOI 10.1592/phco.23.10.1195.32765
-
Marraffa J, Guharoy R, Duggan D, Rose F, Nazeer S. Vancomycin-induced thrombocytopenia: a case proven with rechallenge. Pharmacotherapy 2003:23:1195-1198 (Pubitemid 37158788)
-
(2003)
Pharmacotherapy
, vol.23
, Issue.9 I
, pp. 1195-1198
-
-
Marraffa, J.1
Guharoy, R.2
Duggan, D.3
Rose, F.4
Nazeer, S.5
-
26
-
-
0031047945
-
Vancomycin-induced thrombocytopenia: A challenge and rechallenge
-
Howard CE, Adams LA, Admire JL, Chu MA, Alred GL. Vancomycin-induced thrombocytopenia: a challenge and rechallenge. Ann Pharmacother 1997;31:315-318
-
(1997)
Ann Pharmacother
, vol.31
, pp. 315-318
-
-
Howard, C.E.1
Adams, L.A.2
Admire, J.L.3
Chu, M.A.4
Alred, G.L.5
-
27
-
-
67650819305
-
-
Bristol-Myers Squibb-Sanofi Pharmaceuticals Partnership. Bridgewater, NJ
-
Bristol-Myers Squibb-Sanofi Pharmaceuticals Partnership. Plavix (clopidogrel) package insert. Bridgewater, NJ; 2007.
-
(2007)
Plavix (Clopidogrel) Package Insert
-
-
-
28
-
-
34548542028
-
Two mechanistic pathways for thienopyridine-associated thrombotic thrombocytopenia purpura
-
Bennett CL, Kim B, Zakarija A, et al. Two mechanistic pathways for thienopyridine-associated thrombotic thrombocytopenia purpura. J Am Coll Cardiol 2007;50: 1138-1148
-
(2007)
J Am Coll Cardiol
, vol.50
, pp. 1138-1148
-
-
Bennett, C.L.1
Kim, B.2
Zakarija, A.3
-
29
-
-
2342533038
-
Clopidogrel-Induced Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome after Coronary Artery Stenting
-
DOI 10.1592/phco.24.6.664.34732
-
Manor SM, Guillory GS, Jain SP. Clopidogrel-induced thrombocytopenic purpura-hemolytic uremic syndrome after coronary artery stenting. Pharmacotherapy 2004;24:664-667 (Pubitemid 38585961)
-
(2004)
Pharmacotherapy
, vol.24
, Issue.5 I
, pp. 664-667
-
-
Manor, S.M.1
Guillory, G.S.2
Jain, S.P.3
-
30
-
-
13544250803
-
Immune thrombocytopenia caused by glycoprotein IIb/IIIa inhibitors
-
DOI 10.1378/chest.127.2-suppl.53S
-
Aster RH. Immune thrombocytopenia caused by glycoprotein IIb/IIIa inhibitors. Chest 2005;127:S53-9. (Pubitemid 40224082)
-
(2005)
Chest
, vol.127
, Issue.2 SUPPL.
-
-
Aster, R.H.1
-
31
-
-
0037105428
-
Acute thrombocytopenia after treatment with tirofiban or eptifibatide is associated with antibodies specific for ligand-occupied GPIIb/IIIa
-
Bougie DW, Wilker PR, Wuitschick ED, et al. Acute thrombocytopenia after treatment with tirofiban or eptifibatide is associated with antibodies specific for ligand-occupied GPIIb/IIIa. Blood 2002;100:2071-2076 (Pubitemid 35001239)
-
(2002)
Blood
, vol.100
, Issue.6
, pp. 2071-2076
-
-
Bougie, D.W.1
Wilker, P.R.2
Wuitschick, E.D.3
Curtis, B.R.4
Malik, M.5
Levine, S.6
Lind, R.N.7
Pereira, J.8
Aster, R.H.9
|